We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Next-Generation Models Launched for Sediment Urinalysis Testing

By LabMedica International staff writers
Posted on 05 Oct 2015
Urine sediment analysis is an important test used in diagnosing renal disease and urinary tract disorders and a new model for this analysis has just been launched. More...


Urine testing is divided into urine chemistry, a primary test employing urine test paper, and urine sediment analysis, secondary testing to provide a more detailed analysis of specimens that have been determined to be abnormal during urine chemistry.

Urine sediment analysis is an important test used in diagnosing renal disease and urinary tract disorders. Clinical laboratory technologists use microscopes to observe (microscope testing), classify and measure formed elements in the urine, including red blood cells, white blood cells and bacteria. The ability to perform automated quantitative analysis of formed elements in the urine by using the flow cytometry method was established almost 20 years ago.

Sysmex Corporation (Kobe, Japan) has launched its new products in the sediment urinalysis testing field, the UF-5000/4000/3000 fully automated analyzers of formed elements in urine. The instruments will be rolled out successively on a global scale, beginning with the Japanese market in September 2015. The new models employ blue lasers and other technologies to improve precision and fraction1 and can be used for testing urine and other bodily fluids.

The modular concept is employed to flexibly enable instruments to be added as the number of specimens grows. This concept also allows for future linkage with urine chemistry analyzers and for transport connections among multiple devices at large-scale facilities. Designed to optimize customer usability, the models employ the “Silent Design 3” concept and have simple operating panels. Some RFID4 cassette-type reagents are used to simplify reagent management and replacement.

To contribute to customer operating efficiency, the models are provided in combination with the Urinalysis Work Area Information Management System (U-WAM), which enables urinalysis departments to centrally manage test results. By continuing to provide valuable products in the urinalysis field going forward, Sysmex aims to establish a leading global position in this field of testing.

Related Links:

Sysmex Corporation



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.